340B Health

Manufacturer Inquiries Webinar

Thursday, November 21
1:00 – 2:00 PM ET

DURATION: 60 minutes, including Q&A.

340B Health continues to hear from hospitals that have questions about letters they receive from pharmaceutical manufacturers inquiring into the hospitals’ 340B drug utilization. Manufacturers typically send these “inquiry letters” to hospitals to communicate a concern related to the hospital’s use of 340B drugs and request that the hospital provide information to resolve the issue(s). Some manufacturer inquiries are straightforward and easily resolved, whereas others do not identify a specific compliance concern, yet request a substantial amount of information from hospitals related to how they use 340B drugs.

In this webinar, 340B Health will discuss trends in recent good faith inquiry letters and things hospitals should consider when responding and working with a manufacturer to resolve an issue. A 340B Health member hospital will share its experience responding to different manufacturer inquiries

INTENDED AUDIENCE: C-Suite executives and other authorizing officials, pharmacy directors, in-house counsel, 340B managers, and compliance officers.


  • Amanda Nagrotsky, Legal Counsel, 340B Health
  • Fern Paul-Aviles, Assistant Vice President of 340B and Regulatory Program Compliance, Atrium Health

REGISTRATION: The event is limited to 340B hospitals and 340B Health Corporate Partners; pre-registration is required. To register, please click here. The deadline to register is Tuesday, November 19th.

Registration Category Registration Fee
Enhanced Member Hospital, 340B Health Corporate Partners No charge
Standard, Basic, Affiliate Member Hospital $25
Prospective Member/Non-Members $895

MORE INFORMATION ABOUT THE EVENT: Contact Matt Dorocak at matt.dorocak@340bhealth.org or (202) 536-2286.

MORE INFORMATION AND MEMBERSHIP: For more details about this event, please contact Shane Kelley at shane.kelley@340bhealth.org or (202) 552-5864. For more details on membership, please visit our website.